Study of Novel PET Tracer Gallium [68Ga]/ Fluorine [18F] -FAPI-04 in

Status Recruiting

Clinical Trial Summary

The purpose of this study is to evaluate the safety of fibroblast activating protein receptor imaging agent [68Ga]/ Fluorine [18F] -fibroblast activating protein inhibitor (68Ga/18F-FAPI-04) in clinical application and to verify its effectiveness in the diagnosis of cardiovascular diseases.

Clinical Trial Description

The implementation of this project will promote the research of PET-MRI molecular imaging using the new nuclide imaging with the target of FAP combined with the MRI T1 mapping and ECV measurement technology, realize the fusion of nuclear medicine and magnetic resonance technology in a real sense, dynamically monitor the occurrence and development of myocardial fibrosis in heart failure at an early stage, and establish a complete set of myocardial fibrosis imaging programs. To provide an important basis for the exploration of anti-fibrosis therapy in heart failure and accelerate the pace of clinical transformation of this protocol. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05867589
Study type	Interventional
Source	Nanjing First Hospital, Nanjing Medical University
Contact	Feng Wang
Phone	02552271491
Email	fengwangcn@hotmail.com
Status	Recruiting
Phase	N/A
Start date	May 1, 2023
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03332745` - Mechanism of Decompensation Evaluation - Aortic Stenosis
Not yet recruiting	`NCT05954559` - High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar Assessment	Phase 4
Recruiting	`NCT03176862` - Left Ventricular Fibrosis in Chronic Kidney Disease	N/A
Recruiting	`NCT06039969` - Evaluate Aerobic Exercise on Myocardial Fibrosis and Intestinal Flora in Dilated Cardiomyopathy Diagnosed First Time.
Not yet recruiting	`NCT06059287` - The Effect of Henagliflozin and Metformin on Myocardial Tissue-level Characteristics	N/A
Completed	`NCT00879060` - Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy	Phase 4
Completed	`NCT02834104` - Validation of Fibrosis Quantification Using T1 Mapping Against Histology as Reference and Comparison With Fibrosis Biomarkers	N/A
Active, not recruiting	`NCT04444128` - IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
Recruiting	`NCT03191461` - Myocardial Perfusion and Fibrosis in Cancer Survivors
Recruiting	`NCT02428374` - Role of Immune Responses After Acute Myocardial Infarction	Phase 4
Not yet recruiting	`NCT06326970` - SPECT Fibroblast Activation Protein Imaging in Patients With Cardiac Disease
Completed	`NCT02432885` - Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial	Phase 3
Completed	`NCT04397198` - The Assessment Of Myocardial Viability Based On CTA/MRI Hybrid Models
Recruiting	`NCT03405987` - Association of T1-mapping and LV Strain Analysis by CMR
Completed	`NCT01160471` - Noninvasive Imaging of Heart Failure: A Pilot Study
Completed	`NCT03422770` - Ultrasonic Markers for Myocardial Fibrosis and Prognosis in Aortic Stenosis	N/A
Not yet recruiting	`NCT03515291` - A Trial of Cardiac Injections of iMP Cells During CABG Surgery	Phase 2
Recruiting	`NCT02670031` - Response of the Myocardium to Hypertrophic Conditions in the Adult Population
Terminated	`NCT02012725` - Molecular MRI of the Fibrotic Heart	N/A
Completed	`NCT02727725` - An Evaluation Of The Novel TRAMINER Sequence By Comparison To Late Gadolinium Enhancement Images	N/A

Study of Novel PET Tracer Gallium [68Ga]/ Fluorine [18F] -FAPI-04 in the Diagnosis of Cardiovascular Diseases

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms